Randomized trial on the effectiveness of dexamethasone in TMJ arthrocentesis.

Author(s): Huddleston Slater JJ, Vos LM, Stroy LP, Stegenga B.

Affiliation(s): University of Groningen, Department of Oral Health Care and Clinical Epidemiology, Centre for Dentistry and Oral Hygiene University Medical Centre Groningen, Groningen, The Netherlands. j.j.r.huddleston.slater@kchir.umcg.nl

Publication date & source: 2012, J Dent Res. , 91(2):173-8

The aim of this study was to compare the effectiveness of dexamethasone administration following arthrocentesis of the temporomandibular joint (TMJ) with a placebo (saline). Twenty-eight participants with TMJ arthralgia were randomly assigned to two groups of a parallel double-blind RCT. In both groups, an arthrocentesis procedure was carried out. In one group, the procedure was followed by the administration of a single-dose intra-articular dexamethasone. In the other group, saline was administered as a control. Follow-up visits were scheduled after 1, 3, and 24 weeks. During each visit, TMJ pain (on a 100-mm VAS) and jaw stiffness (mouth opening in mm) were scored. In the statistical analysis, generalized estimating equation (GEE) models showed no differences between the two study groups, although pain and jaw stiffness were both reduced over 24 weeks. In conclusion, intra-articular dexamethasone following arthrocentesis did not improve the procedure's effect in patients presenting with TMJ arthralgia (ClinicalTrials.gov number CT01275014).